Identity Development in Youth With Neuromuscular Diseases
NCT ID: NCT03775135
Last Updated: 2018-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2019-01-01
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This project examines three underlying intrapersonal processes possibly having an impact on the evolution of these secondary symptoms. Previous research confirmed the significant impact of having a chronic illness on the development of identity and the association with a higher prevalence of depressive symptoms. Identity formation is a crucial developmental task to transfer from a child to an independent, responsible adult. We believe this developmental task is more at risk for youngsters and young adults suffering from a physical disability, caused by a neuromuscular disease. In this longitudinal research project, we investigate the development of identity in youth with a neuromuscular disease, compared to healthy peers and compared to a group of peers with a non-visible chronical illness. We also evaluate the impact of the degree of physical functioning on those mechanisms. Second, we examine if parental behavior and parental functioning is linked with the formation of identity in a neuromuscular populations. Finally, the impact of identity formation on psychosocial outcomes (e.g. feelings of depression and anxiety, quality of life, …) is measured.
By addressing these research questions, this project will add substantially to our knowledge on identity in chronic illness and can inform future prevention and intervention efforts targeting illness adaptation and parental functioning in order to prevent negative psychosocial outcomes and to optimize quality of life.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To investigate our objectives, data will be systematically collected during two years on two different occasions (T1 and T2), with one year between subsequent time-points. All neuromuscular patients are supposed to consult their multidisciplinary team every 6 months in the context of a general control and this gives us the opportunity to ask both adolescents and parents to complete questionnaires once a year. Depending on the date of the appointment, patients will start in this survey on different moments, but we will use the same time interval between time-points for every single patient. For inclusion, adolescents and parents will be asked to sign informed consents, where after demographic and clinical data can be obtained anonymously from the patients' medical records. Additional demographic and socio-economic information will be gathered using a demographic questionnaire at T1. Other data will be collected using instruments with well-established psychometric characteristics that mostly include self-reports on all two time-points (T1 and T2). Parents will also be asked to report on youth functioning as well. Figure 2 shows an overview of our research design and estimated timeline.
In order to investigate objective 1, adolescents will be asked to complete following questionnaires on the two different time-points: Dimensions of Identity Development Scale (25 items), Illness Identity Resolution Scale (27 items) and Brief Illness Perception Questionnaire (8 items). In addition, to examine reciprocal associations between identity development and the variables forwarded under objectives 2 en 3, adolescents will be asked to complete self-report questionnaires on psychosocial functioning and perceived support, using the Center for Epidemiologic Studies Depression Scale (CESD) (20 items) to screen for depressive symptoms, the Screen for Child Anxiety Related Emotional Disorders (SCARED-NL), the PedsQLTM Neuromuscular Module to measure quality of life and the Inventory of Peer and Parent Attachment: subscales Trust, Communication and Alienation (12 items). At the same time-points parents will be asked to complete the Illness Intrusive Scale (13 items), a scale about different factors of their parenting: responsiveness (7 items), psychological control (8 items), behavioral control (7 items) and overprotection/anxious parenting (8 items) (Parenting Questionnaire) and about the physical dependence of their child (Activ-Lim). To report about the psychosocial functioning of their child, parents will be asked to fulfill the Screen for Child Anxiety Related Emotional Disorders (SCARED-NL) and the PedsQLTM Neuromuscular Module to measure perceived quality of life in the youngster. For evaluating their own psychosocial functioning, they will be asked to complete the Center for Epidemiologic Studies Depression Scale (20 items) and a LAS-scale to evaluate their own quality of life. Necessary measures will be taken to minimize dropout: all participants receive a reward and Dillman's approach will be used to minimize non-response. Occasional missing data will be dealt with using appropriate methods (Enders, 2010). State-of-the-art longitudinal techniques will be used. Cross-lagged analysis will be used to examine directionality of effect, with appropriate controls for all within-time associations and stability coefficients. Hence, we can investigate, for instance, whether parents actually predict illness identity resolutions over time or whether reciprocal effects emerge with, for instance, illness acceptance also leading to more support. Further, mediation will be tested from a longitudinal perspective, allowing us to examine, for instance, whether illness identity resolutions mediate the associations between parental support and outcomes. To chart developmental trajectories over time, latent growth curve modeling estimates both linear and non-linear growth and uses information collected at all different time points to derive parameters of change (i.e., intercept and slope). Finally, latent class growth analysis will be used to identify distinct developmental trajectory classes in terms of personal and illness identity resolutions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Children with neuromuscular diseases
Questionnaires will be administered by children with neuromuscular disease between 12 and 25 years and their parents
Questionnaires
Different questionnaires about identity development and psychosocial functioning will be administered
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires
Different questionnaires about identity development and psychosocial functioning will be administered
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 12-25 years at baseline;
* last neuromuscular consult at our NMRC is 5 or less years ago;
* able to read and write Dutch;
* valid contact details available in the clinical database or the hospital information system.
12 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie Goemans, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
UZ Leuven
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S0000
Identifier Type: -
Identifier Source: org_study_id